471 related articles for article (PubMed ID: 29972798)
1. Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling.
Luo M; Shang L; Brooks MD; Jiagge E; Zhu Y; Buschhaus JM; Conley S; Fath MA; Davis A; Gheordunescu E; Wang Y; Harouaka R; Lozier A; Triner D; McDermott S; Merajver SD; Luker GD; Spitz DR; Wicha MS
Cell Metab; 2018 Jul; 28(1):69-86.e6. PubMed ID: 29972798
[TBL] [Abstract][Full Text] [Related]
2. Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells.
Kamble D; Mahajan M; Dhat R; Sitasawad S
Cells; 2021 Jan; 10(1):. PubMed ID: 33419140
[TBL] [Abstract][Full Text] [Related]
3. Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses.
Luo M; Wicha MS
Semin Radiat Oncol; 2019 Jan; 29(1):42-54. PubMed ID: 30573183
[TBL] [Abstract][Full Text] [Related]
4. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
Roh JL; Jang H; Kim EH; Shin D
Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Nrf2-regulated antioxidant cell response inhibits HEMA-induced oxidative stress and supports cell viability.
Gallorini M; Petzel C; Bolay C; Hiller KA; Cataldi A; Buchalla W; Krifka S; Schweikl H
Biomaterials; 2015 Jul; 56():114-28. PubMed ID: 25934285
[TBL] [Abstract][Full Text] [Related]
6. ROS-independent ER stress-mediated NRF2 activation promotes warburg effect to maintain stemness-associated properties of cancer-initiating cells.
Chang CW; Chen YS; Tsay YG; Han CL; Chen YJ; Yang CC; Hung KF; Lin CH; Huang TY; Kao SY; Lee TC; Lo JF
Cell Death Dis; 2018 Feb; 9(2):194. PubMed ID: 29416012
[TBL] [Abstract][Full Text] [Related]
7. ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2.
Luo M; Bao L; Xue Y; Zhu M; Kumar A; Xing C; Wang JE; Wang Y; Luo W
J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38488001
[TBL] [Abstract][Full Text] [Related]
8. Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells.
Tanaka G; Inoue K; Shimizu T; Akimoto K; Kubota K
Cancer Med; 2016 Sep; 5(9):2544-57. PubMed ID: 27485632
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.
Rodman SN; Spence JM; Ronnfeldt TJ; Zhu Y; Solst SR; O'Neill RA; Allen BG; Guan X; Spitz DR; Fath MA
Radiat Res; 2016 Oct; 186(4):385-395. PubMed ID: 27643875
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells
Kim DH; Jang JH; Kwon OS; Cha HJ; Youn HJ; Chun KS; Surh YJ
Antioxid Redox Signal; 2020 Jun; 32(18):1313-1329. PubMed ID: 31672029
[No Abstract] [Full Text] [Related]
11. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis.
Yang X; Liang B; Zhang L; Zhang M; Ma M; Qing L; Yang H; Huang G; Zhao J
Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38847277
[TBL] [Abstract][Full Text] [Related]
14. Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer.
Ren Z; Liang H; Galbo PM; Dharmaratne M; Kulkarni AS; Fard AT; Aoun ML; Martinez-Lopez N; Suyama K; Benard O; Zheng W; Liu Y; Albanese J; Zheng D; Mar JC; Singh R; Prystowsky MB; Norton L; Hazan RB
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35193955
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress induces senescence in breast cancer stem cells.
Zhong G; Qin S; Townsend D; Schulte BA; Tew KD; Wang GY
Biochem Biophys Res Commun; 2019 Jul; 514(4):1204-1209. PubMed ID: 31109646
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.
Li L; Fath MA; Scarbrough PM; Watson WH; Spitz DR
Redox Biol; 2015; 4():127-35. PubMed ID: 25560241
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
[TBL] [Abstract][Full Text] [Related]
18. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
19. The PRAK-NRF2 axis promotes the differentiation of Th17 cells by mediating the redox homeostasis and glycolysis.
Zhao Z; Wang Y; Gao Y; Ju Y; Zhao Y; Wu Z; Gao S; Zhang B; Pang X; Zhang Y; Wang W
Proc Natl Acad Sci U S A; 2023 May; 120(19):e2212613120. PubMed ID: 37126714
[TBL] [Abstract][Full Text] [Related]
20. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
